Buminate (Baxalta US Inc.)
Welcome to the PulseAid listing for the Buminate drug offered from Baxalta US Inc.. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | Baxalta US Inc. |
NON-PROPRIETARY NAME: | Albumin Human |
SUBSTANCE NAME: | ALBUMIN HUMAN |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1954-03-17 |
END MARKETING DATE: | 0000-00-00 |
Buminate PLASMA DERIVATIVE Details:
Item Description | Buminate from Baxalta US Inc. |
LABELER NAME: | Baxalta US Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.25(g/mL) |
START MARKETING DATE: | 1954-03-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0944-0490_2d4ce1ae-31d8-495e-855b-e1a587631e67 |
PRODUCT NDC: | 0944-0490 |
APPLICATION NUMBER: | BLA101452 |
Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers: